Serial #85925734
DEAD

Serial Number

85925734

Owner

ABBOTT MOLECULAR INC.

Attorney

Michele H. Bowman

Filing Date

May 7, 2013

Add to watchlist:

No watchlists yet
View on USPTO

Serial #85925734 Trademark

Serial Number: 85925734

Serial #85925734 is a trademark filed by ABBOTT MOLECULAR INC. on May 7, 2013. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

ABBOTT MOLECULAR INC. (23 trademarks)

100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064

Entity Type: 03

Trademark Details

Filing Date

May 7, 2013

Registration Date

Not Registered

Published for Opposition

May 27, 2014

Goods & Services

Promoting pharmacogenomics, molecular diagnostics and companion diagnostics goods and services of others; consulting regarding regulatory matters, namely, clinical data and regulatory submission management and strategic counseling related to clinical testing, review and approval of diagnostic tests paired with specific therapies, in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics; retail store and wholesale store services featuring diagnostic test kits; retail store and wholesale store services featuring diagnostic reagents; retail store and wholesale store services featuring diagnostic kits composed of DNA probes, reagents and antibodies; retail store and wholesale store services featuring test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; retail store and wholesale store services featuring test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; retail store and wholesale store services featuring computer software and hardware in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics

Pharmacogenomics services, namely, medical testing for diagnostic or treatment purposes; molecular diagnostics services, namely, medical testing for diagnostic or treatment purposes; companion diagnostics services, namely, medical testing for diagnostic or treatment purposes and managing patient medical testing, namely, medical diagnostic testing monitoring and reporting services; providing information relating to pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposes; providing a website featuring information in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposes; consulting in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for treatment and diagnostic purposes

Scientific and technological research and development services in the areas of pharmacogenomics, molecular diagnostics and companion diagnostics; development of companion diagnostics; Pharmacogenomics research services, namely, biomarker discovery services; molecular diagnostic research services; companion diagnostics research and development of medical tests for diagnosis and treatment; providing information relating to pharmacogenomics, molecular diagnostics and companion diagnostics for research purposes; providing a website featuring information in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for research purposes; consulting in the fields of pharmacogenomics, molecular diagnostics and companion diagnostics for research purposes

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Aug 28, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 28, 2017 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 31, 2017 EXRA
SOU EXTENSION 5 GRANTED
Jan 30, 2017 EX5G
SOU EXTENSION 5 FILED
Jan 23, 2017 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 23, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 30, 2016 EXRA
SOU EXTENSION 4 GRANTED
Jul 29, 2016 EX4G
SOU EXTENSION 4 FILED
Jul 21, 2016 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 21, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 2, 2016 EXRA
SOU EXTENSION 3 GRANTED
Feb 1, 2016 EX3G
SOU EXTENSION 3 FILED
Jan 21, 2016 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 21, 2016 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 30, 2015 EXRA
SOU EXTENSION 2 GRANTED
Jul 29, 2015 EX2G
SOU EXTENSION 2 FILED
Jul 22, 2015 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 22, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 12, 2015 EXRA
SOU EXTENSION 1 GRANTED
Mar 11, 2015 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 10, 2015 AITU
SOU EXTENSION 1 FILED
Jan 22, 2015 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 22, 2015 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 22, 2014 NOAM
NOTICE OF PUBLICATION
May 28, 2014 NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 27, 2014 NPUB
PUBLISHED FOR OPPOSITION
May 27, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 7, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 21, 2014 PREV
ASSIGNED TO LIE
Apr 19, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 28, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 21, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 21, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 21, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 21, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 28, 2014 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 30, 2013 GNRN
NON-FINAL ACTION E-MAILED
Aug 30, 2013 GNRT
NON-FINAL ACTION WRITTEN
Aug 30, 2013 CNRT
ASSIGNED TO EXAMINER
Aug 24, 2013 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 17, 2013 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 16, 2013 NWOS
NEW APPLICATION ENTERED
May 10, 2013 NWAP